Growing advancements in haemophilia treatment underscore a significant shift toward targeted and long-lasting therapeutic ...

Saliva activates coagulation in persons with hemophilia A. ScienceDaily. Retrieved January 28, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250114125253.htm Medical University of Vienna.

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with hemophilia A, the most common form of hemophilia. The research team was able to show ...

UC San Diego announced that it is offering a newly Food and Drug Administration-approved gene therapy for hemophilia B, a ...

More information: Johannes Thaler et al, Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexes, Blood (2024). DOI: 10.1182/blood.2024025093 Journal information: Blood ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that ...

After having a bad experience getting three vaccines at once, columnist Jennifer Lynne says that next time, she'll space them apart.

Hemophilia B causes a deficiency in factor IX, a protein necessary for blood clotting. Replacement factor IX therapy is the gold standard treatment, but novel and genetic therapies are showing ...

The recent announcement by the government to provide free medicines for hemophilia patients is a welcome step forward in ...

Saliva Activates Coagulation in Persons With Hemophilia A Jan. 14, 2025 — A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common ...